compound semaglutide ending glp 1 Switching from a compounded to a brand-name GLP-1? Here's how to do it in 5 steps Compound versions of GLP-1 drugs – FDA moves to remove GLP-1

Source: Pocket Manual of Therapy (Bartoccioni et al.) / FDA News To view or add a comment, sign in 186 followers

Eso se debe a mejoras en la glucosa y la presin arterial, factores clave para el corazn

Preclinical Data Point to a Meaningful Competitive Edge Preclinical data from SureNano Science suggest that GEP-44 may offer substantive differentiation relative to earlier-generation GLP therapies

ERJ Open Res 2022;8

Current research focuses on several key strategies, from enhancing amylin stability by attaching polyethylene glycol or carbohydrate molecules to amylin, to developing oral amylin formulations to improve patients convenience, as well as developing various combination therapies to enhance weight loss and glucose regulation by targeting multiple receptors in metabolic pathways

They are the same problem showing up in two places